Amgen

YTD

ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.

CEO

Robert A. Bradway

CEORobert A. Bradway

Employees

31,500

Employees31,500

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

1980

Founded1980

Employees

31,500

Employees31,500

AMGN Key Statistics

Market cap

192.81B

Market cap192.81B

Price-Earnings ratio

24.71

Price-Earnings ratio24.71

Dividend yield

2.76%

Dividend yield2.76%

Average volume

2.08M

Average volume2.08M

High today

$358.11

High today$358.11

Low today

$353.95

Low today$353.95

Open price

$354.74

Open price$354.74

Volume

196.75K

Volume196.75K

52 Week high

$391.29

52 Week high$391.29

52 Week low

$269.77

52 Week low$269.77

Stock Snapshot

As of today, Amgen(AMGN) shares are valued at $357.24. The company's market cap stands at 192.81B, with a P/E ratio of 24.71 and a dividend yield of 2.76%.

During the trading session on 2026-07-15, Amgen(AMGN) shares reached a daily high of $358.11 and a low of $353.95. At a current price of $357.24, the stock is +0.9% higher than the low and still -0.2% under the high.

Trading activity shows a volume of 196.75K, compared to an average daily volume of 2.08M.

The stock's 52-week range extends from a low of $269.77 to a high of $391.29.

AMGN News

MarketWatch 18h

Amgen Inc. stock outperforms competitors despite losses on the day - MarketWatch

...

24/7 Wall St. 23h

Pfizer Vs. Amgen: Bet That Pfizer's Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen

This lithium producer surpassed a $1B private valuation, joining some of America's most powerful startups. Now you can invest in EnergyX alongside global giants...

Simply Wall St 2d

Amgen Recalls Corlanor And Sensipar Nationwide Over Quality Control Issues

Amgen has initiated multiple nationwide recalls of certain lots of Corlanor (ivabradine) and Sensipar (cinacalcet). The recalls are tied to quality control iss...

Analyst ratings

49%

of 35 ratings

Buy

40%

Hold

48.6%

Sell

11.4%

More AMGN News

TipRanks 2d

Amgen price target raised to $420 from $400 at UBS

UBS raised the firm’s price target on Amgen (AMGN) to $420 from $400 and keeps a Buy rating on the shares. TipRanks has entered a new arena in the investing wo...

TipRanks 2d

Analyst Maintains Sell on Amgen as Shares Trade Above Newly Raised $312 Price Target and Near-Term Growth Remains Limited

In a report released today, Tazeen Ahmad from Bank of America Securities reiterated a Sell rating on Amgen, with a price target of $312.00. TipRanks has entere...

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.